| Market Cap | ₹1,929Cr |
| ROE | 16.57% |
| P/E Ratio(TTM) | 34.02 |
| EPS(TTM) | 19.61 |
| P/B Ratio | 5.64 |
| Dividend Yield | 0.69% |
| Industry P/E | 40.04 |
| Book Value | 118.32 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Parent Organisation | Amrutanjan Health Care Limited |
| Managing Director | S. Sambhu Prasad |
| Founded | 1893 |
| NSE Symbol | AMRUTANJAN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Ajanta Pharma | NA (0.00%) | 37.68 | ||
| Gland Pharma | NA (0.00%) | 35.76 | ||
| Eris Lifesciences | NA (0.00%) | 45.49 |